Bluebird Bio's total assets for Q3 2024 were $465.06M, a decrease of -14.70% from the previous quarter. BLUE total liabilities were $470.84M for the fiscal quarter, a -4.34% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.